HU-211 (Dexanabinol), a putative neuroprotective agent, was evaluated in a number of
animal models including closed head injury, optic nerve crush, global ischemia and focal …

Dexanabinol, HU-211, a synthetic cannabinoid devoid of psychotropic effects, improves
neurological outcome in models of brain trauma, ischemia and meningitis. Recently, HU-211 …

HU-211, a nonpsychotropic cannabinoid and a noncompetitive NMDA antagonist, was tested
in a global ischemia model in the Mongolian gerbil. Male Mongolian gerbils underwent a …

The therapeutic potential of cannabinoids has been described previously for several inflammatory
diseases, but the molecular mechanisms underlying the anti-inflammatory properties …

The purpose of the present study was to examine the dose-response relationship and the
therapeutic time window for the synthetic nonpsychotropic cannabinoid (HU-211) as a …

The interaction of 7-hydroxy-Δ 6 -tetrahydrocannabinol 1,1-dimethylheptyl (Dexanabinol; HU-211),
a novel NMDA receptor antagonist, with the dopaminergic system was examined …

… Available here in English for the first time, Uri Bar-Joseph has crafted an authoritative
explanation of the most traumatic event in Israel s stormy history and one of the biggest strategic …

Veteran Israeli and American intelligence officers whom I interviewed cleared much of the fog
that clouded certain historical aspects of this study, especially in connection with the Israeli…

This volumes discusses three principal issues: the Israeli army and the Revolution of
Military Affairs (RMA); Israel's present and future answers to the threays of weapons of mass …

… I would like to acknowledge the helpful comments of Avi Ben-Zvi, Benjamin Miller, Ben D. …
For a discussion of the Rotem crisis, see Uri Bar-Joseph, "Rotem: The Forgotten Crisis on the …